# First double-blind controlled trial of TNS shows reduced symptoms in some children with ADHD

**URL:** <https://archive.menshealtharchive.com/t/first-double-blind-controlled-trial-of-tns-shows-reduced-symptoms-in-some-children-with-adhd/1788>\
**Category:** Research Database\
**Created:** [March 13, 2019, 4:05pm UTC](https://archive.menshealtharchive.com/t/first-double-blind-controlled-trial-of-tns-shows-reduced-symptoms-in-some-children-with-adhd/1788 "2019-03-13T16:05:09Z")\
**Posts on this page:** 1\
**Page:** 1

<div class="post-metadata">

**Author:** ![Science\_Daily](https://yyz1.discourse-cdn.com/flex035/user_avatar/archive.menshealtharchive.com/science_daily/32/325_2.png) [@Science\_Daily](https://archive.menshealtharchive.com/u/Science_Daily)\
**Post date:** [March 13, 2019, 4:05pm UTC](https://archive.menshealtharchive.com/t/first-double-blind-controlled-trial-of-tns-shows-reduced-symptoms-in-some-children-with-adhd/1788/1 "2019-03-13T16:05:09Z")

</div>

> **[First double-blind controlled trial of TNS shows reduced symptoms in some...](https://www.sciencedaily.com/releases/2019/03/190312103654.htm)**
>
> Currently approved in Canada and Europe for adults with medication-resistant depression and seizures, trigeminal nerve stimulation (TNS) has been found to be an effective and safe means of treatment for children with attention deficit hyperactivity...

  
Currently approved in Canada and Europe for adults with medication-resistant depression and seizures, trigeminal nerve stimulation (TNS) has been found to be an effective and safe means of treatment for children with attention deficit hyperactivity disorder (ADHD), reports a new study.